chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
COMMON RH et al. | Modification of the biochemical responses of the immature pullet to oestrogen by means of dietary aureomycin. | 1950 | Nature | pmid:14796662 |
SCANGA F | [In vitro effect of aureomycin on various strains of Brucella and Salmonella]. | 1950 | Rend Ist Sup Sanit | pmid:14844778 |
CHANDLER CA and HODES HL | Aureomycin in the treatment of experimental and clinical infections with H. influenzae, type B. | 1950 | Pediatrics | pmid:15405442 |
de FAGONDE AP | [Study of the sensitivity in vitro of some anaerobic bacteria to aureomycin]. | 1950 | Ann Inst Pasteur (Paris) | pmid:14811121 |
SIEGEL JM and SCHANTZ ET | Aureomycin: its topical use in cutaneous pyogenic infections and its sensitizing potentialities. | 1950 | Am Pract Dig Treat | pmid:15413753 |
SCHWARTZ WS et al. | Aureomycin in the treatment of tuberculosis. | 1950 | Am Rev Tuberc | pmid:15413773 |
HVID-HANSEN N | [Aureomycin therapy of virus pneumonia]. | 1950 | Ugeskr. Laeg. | pmid:15443117 |
LoPRESTI JM et al. | Aureomycin in the treatment of resistant bacilluria. | 1950 | Pediatrics | pmid:15417273 |
SENEAR FE | Pemphigus vulgaris; remission after treatment with aureomycin. | 1950 | Arch Derm Syphilol | pmid:15419826 |
SEED JC and WILSON CE | The effect of aluminum hydroxide on serum aureomycin concentrations after simultaneous oral administration. | 1950 | Bull Johns Hopkins Hosp | pmid:15420551 |
ELLIOTT DC | Effect of aureomycin in ocular complications of leprosy. | 1950 | Am. J. Ophthalmol. | pmid:15425595 |
SINGER JJ | Diseases of the respiratory system. | 1950 | Annu. Rev. Med. | pmid:14771854 |
ROCCHIETTA S | [Magistral preparations of aureomycin]. | 1950 | Boll Chim Farm | pmid:15434116 |
SAWICKY HH et al. | Therapeutic assays of the Skin and Cancer Unit of the New York University Hospital. | 1950 | J. Invest. Dermatol. | pmid:14779050 |
HENRICSON HO | The effect of aureomycin on herpetic corneal affections and trachoma. | 1950 | Acta Ophthalmol (Copenh) | pmid:14846564 |
STEEN E | Acute experimental toxoplasmosis treated with aureomycin. | 1950 | Acta Pathol Microbiol Scand | pmid:14846635 |
AINSLIE D | Aureomycin in ophthalmology. | 1950 | Br J Ophthalmol | pmid:14791932 |
GAUCHERAND J et al. | [First results of treatment of acute puerperal mastitis with aureomycin]. | 1950 | Bull Fed Soc Gynecol Obstet Lang Fr | pmid:14792153 |
BOOKMAN R | Kaposi's varicelliform eruption; report of a case treated with aureomycin and some observations regarding the course of the underlying skin disease. | 1950 | J Allergy | pmid:15400301 |
WOODWARD TE and BAUER RE | Present status of aureomycin and chloramphenicol therapy. | 1950 | Bull Sch Med Univ Md | pmid:15400537 |